30 articles for P Delagrange
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
New quinolinic derivatives as melatonergic ligands: Synthesis and pharmacological evaluation.
Universities of Lille
Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.
University of Lille
Synthesis of 2-arylfuro[3,2-b]pyridines: Effect of the C2-aryl group on melatoninergic activity.
Orleans University
Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines.
University of Urbino
Synthesis of new N-(arylcyclopropyl)acetamides and N-(arylvinyl)acetamides as conformationally-restricted ligands for melatonin receptors.
Paris-Sud University
Novel and selective partial agonists of 5-HT3 receptors. 2. Synthesis and biological evaluation of piperazinopyridopyrrolopyrazines, piperazinopyrroloquinoxalines, and piperazinopyridopyrroloquinoxalines.
University of Caen Normandy
Novel selective and partial agonists of 5-HT3 receptors. Part 1. Synthesis and biological evaluation of piperazinopyrrolothienopyrazines.
University of Caen Normandy
Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT(1) melatoninergic ligands.
University of Lille
Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I).
University of Lille
Design and synthesis of 2-phenylimidazo[1,2-a]pyridines as a novel class of melatonin receptor ligands.
Orleans University
Preparation and pharmacological evaluation of a novel series of 2-(phenylthio)benzo[b]thiophenes as selective MT2 receptor ligands.
University of Lille
Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.
University of Lille
Design and synthesis of 1-(2-alkanamidoethyl)-6-methoxy-7-azaindole derivatives as potent melatonin agonists.
Orleans University
Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
University of Lille 2
Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3.
Université
3-[5-(4,5-dihydro-1H-imidazol-2-yl)-furan-2-yl]phenylamine (Amifuraline), a promising reversible and selective peripheral MAO-A inhibitor.
Università
Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands.
Université
Synthesis and structure-affinity-activity relationships of novel benzofuran derivatives as MT(2) melatonin receptor selective ligands.
Institut De Chimie Pharmaceutique Albert Lespagnol
Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).
Institut De Chimie Pharmaceutique Albert Lespagnol
Quinazoline and phthalazine derivatives as novel melatonin receptor ligands analogues of agomelatine.
Umr-S1172 - Jparc - Centre De Recherche Jean-Pierre Aubert Neurosciences Et Cancer
Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors.
Paris-Sud University
Original Design of Fluorescent Ligands by Fusing BODIPY and Melatonin Neurohormone.
Orleans University
Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.
University of Paris
Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.
Cnrs-Biocis
Design and synthesis of new naphthalenic derivatives as ligands for 2-[125I]iodomelatonin binding sites.
Cnrs-Biocis
Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands.
Institut De Chimie Pharmaceutique
Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MT
Univ. Lille
Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor Ligands.
University of Parma
